Alterations in the rat serum proteome during liver injury from acetaminophen exposure

Journal of Pharmacology and Experimental Therapeutics

Volumn 318, Issue 2, 2006, Pages 792-802

  Merrick, B Alex ^a   Bruno, Maribel E ^a   Madenspacher, Jennifer H ^a   Wetmore, Barbara A ^a   Foley, Julie ^a   Pieper, Rembert ^b   Zhao, Ming ^b   Makusky, Anthony J ^b   McGrath, Andrew M ^b   Zhou, Jeff X ^b   Taylor, John ^b   Tomer, Kenneth B ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b Large Scale Biology Corporation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYPHENYLPYRUVATE DIOXYGENASE; ACTIN RELATED PROTEIN 3; ADENOSYLHOMOCYSTEINASE; ALPHA 1 ANTITRYPSIN; AMINOPEPTIDASE; APOLIPOPROTEIN E; BETA ACTIN; BETA2 GLYCOPROTEIN 1; CARBONATE DEHYDRATASE II; CARRIER PROTEIN; CATALASE; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4A; CYTOKINE; FUMARYLACETOACETASE; GLUTATHIONE SYNTHASE; GLYCOGEN PHOSPHORYLASE; GUANINE DEAMINASE; HAPTOGLOBIN; HEAT SHOCK PROTEIN 70; HEMOPEXIN; HISTIDINE AMMONIALYASE; METALLOPROTEINASE INHIBITOR; MONOCYTE CHEMOTACTIC PROTEIN 1; PARACETAMOL; PLASMA PROTEIN; PREALBUMIN; PROTEOME; TUMOR NECROSIS FACTOR ALPHA; UROCANATE HYDRATASE;

ACUTE PHASE RESPONSE; ALANINE AMINOTRANSFERASE BLOOD LEVEL; AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BLOOD CLOTTING; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HISTOPATHOLOGY; INFLAMMATION; LIVER INJURY; MALE; MASS SPECTROMETRY; METABOLISM; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; RAT; TWO DIMENSIONAL GEL ELECTROPHORESIS; WESTERN BLOTTING;

ACETAMINOPHEN; ALANINE TRANSAMINASE; ANALGESICS, NON-NARCOTIC; ANIMALS; ASPARTATE AMINOTRANSFERASES; BLOOD PROTEINS; BLOTTING, WESTERN; CATALASE; ELECTROPHORESIS, POLYACRYLAMIDE GEL; HEPATITIS, TOXIC; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MASS SPECTROMETRY; PROTEOME; RATS; RATS, INBRED F344;

EID: 33745945069     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.106.102681     Document Type: Article

References (40)

1. Amacher DE, Adler R, Herath A, and Townsend RR (2005) Use of proteomic methods to identify serum biomarkers associated with rat liver toxicity or hypertrophy. Clin Chem 51:1796-1803.
2. Apple FS, Wu AH, Mair J, Ravkilde J, Panteghini M, Tate J, Pagani F, Christenson RH, Mockel M, Danne O, et al. (2005) Future biomarkers for detection of ischemia and risk stratification in acute coronary syndrome. Clin Chem 51:810-824.
3. Bhat VB, Choi MH, Wishnok JS, and Tannenbaum SR (2005) Comparative plasma proteome analysis of lymphoma-bearing SJL mice. J Proteome Res 4:1814-1825.
4. Dambach DM, Durham SK, Laskin JD, and Laskin DL (2005) Distinct roles of NF-kappaB p50 in the regulation of acetaminophen-induced inflammatory mediator production and hepatotoxicity. Toxicol Appl Pharmacol 211:157-165.
5. Dambach DM, Watson LM, Gray KR, Durham SK, and Laskin DL (2002) Role of CCR2 in macrophage migration into the liver during acetaminophen-induced hepatotoxicity in the mouse. Hepatology 35:1093-1103.
6. Fountoulakis M, Berndt P, Boelsterli UA, Crameri F, Winter M, Albertini S, and Suter L (2000) Two-dimensional database of mouse liver proteins: changes in hepatic protein levels following treatment with acetaminophen or its nontoxic regioisomer 3-acetamidophenol. Electrophoresis 21:2148-2161.
7. Gardner CR, Laskin JD, Dambach DM, Chiu H, Durham SK, Zhou P, Bruno M, Gerecke DR, Gordon MK, and Laskin DL (2003) Exaggerated hepatotoxicity of acetaminophen in mice lacking tumor necrosis factor receptor-1. Potential role of inflammatory mediators. Toxicol Appl Pharmacol 192:119-130.
8. Hammerschmidt S and Wahn H (2004) The oxidants hypochlorite and hydrogen peroxide induce distinct patterns of acute lung injury. Biochim Biophys Acta 1690:258-264.
9. Heinloth AN, Irwin RD, Boorman GA, Nettesheim P, Fannin RD, Sieber SO, Snell ML, Tucker CJ, Li L, Travlos GS, et al. (2004) Gene expression profiling of rat livers reveals indicators of potential adverse effects. Toxicol Sci 80:193-202.
10. Hinson JA, Reid AB, McCullough SS, and James LP (2004) Acetaminophen-induced hepatotoxicity: role of metabolic activation, reactive oxygen/nitrogen species and mitochondrial permeability transition. Drug Metab Rev 36:805-822.
11. Ikemoto M, Tsunekawa S, Toda Y, and Totani M (2001) Liver-type arginase is a highly sensitive marker for hepatocellular damage in rats. Clin Chem 47:946-948.
12. Jaeschke H, Cover C, and Bajt ML (2005) Inflammation and drug hepatotoxicity: aggravation of injury or clean-up mission? Hepatology 41:1176-1178.
13. James LP, Kurten RC, Lamps LW, McCullough S, and Hinson JA (2005a) Tumour necrosis factor receptor 1 and hepatocyte regeneration in acetaminophen toxicity: a kinetic study of proliferating cell nuclear antigen and cytokine expression. Basic Clin Pharmacol Toxicol 97:8-14.
14. James LP, Mayeux PR, and Hinson JA (2003) Acetaminophen-induced hepatotoxicity. Drug Metab Dispos 31:1499-1506.
15. James LP, Simpson PM, Farrar HC, Kearns GL, Wasserman GS, Blumer JL, Reed MD, Sullivan JE, and Hinson JA (2005b) Cytokines and toxicity in acetaminophen overdose. J Clin Pharmacol 45:1165-1171.
16. Kon K, Kim JS, Jaeschke H, and Lemasters JJ (2004) Mitochondrial permeability transition in acetaminophen-induced necrosis and apoptosis of cultured mouse hepatocytes. Hepatology 40:1170-1179.
17. Laskin DL (1996) Sinusoidal lining cells and hepatotoxicity. Toxicol Pathol 24:112-118.
18. Lawson JA, Farhood A, Hopper RD, Bajt ML, and Jaeschke H (2000) The hepatic inflammatory response after acetaminophen overdose: role of neutrophils. Toxicol Sci 54:509-516.
19. Lee WM and Galbraith RM (1992) The extracellular actin-scavenger system and actin toxicity. N Engl J Med 326:1335-1341.
20. Leff JA, Oppegard MA, Terada LS, McCarty EC, and Repine JE (1991) Human serum catalase decreases endothelial cell injury from hydrogen peroxide. J Appl Physiol 71:1903-1906.
21. Li J, Li W, Su J, Liu W, Altura BT, and Altura BM (2003) Hydrogen peroxide induces apoptosis in cerebral vascular smooth muscle cells: possible relation to neurodegenerative diseases and strokes. Brain Res Bull 62:101-106.
22. Liu ML, Mars WM, Zarnegar R, and Michalopoulos GK (1994) Uptake and distribution of hepatocyte growth factor in normal and regenerating adult rat liver. Am J Pathol 144:129-140.
23. Liu ZX, Govindarajan S, and Kaplowitz N (2004) Innate immune system plays a critical role in determining the progression and severity of acetaminophen hepatotoxicity. Gastroenterology 127:1760-1774.
24. Markiewski MM, Mastellos D, Tudoran R, DeAngelis RA, Strey CW, Franchini S, Wetsel RA, Erdei A, and Lambris JD (2004) C3a and C3b activation products of the third component of complement (C3) are critical for normal liver recovery after toxic injury. J Immunol 173:747-754.
25. Mohammed FF, Pennington CJ, Kassiri Z, Rubin JS, Soloway PD, Ruther U, Edwards DR, and Khokha R (2005) Metalloproteinase inhibitor TIMP-1 affects hepatocyte cell cycle via HGF activation in murine liver regeneration. Hepatology 41:857-867.
26. Musana KA, Yale SH, and Abdulkarim AS (2004) Tests of liver injury. Clin Med Res 2:129-131.
27. O'Brien PJ, Slaughter MR, Polley SR, and Kramer K (2002) Advantages of glutamate dehydrogenase as a blood biomarker of acute hepatic injury in rats. Lab Anim 36:313-321.
28. Omenn GS, States DJ, Adamski M, Blackwell TW, Menon R, Hermjakob H, Apweiler R, Haab BB, Simpson RJ, Eddes JS, et al. (2005) Overview of the HUPO Plasma Proteome Project: results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 proteins and a publicly-available database. Proteomics 5:3226-3245.
29. Park BK, Kitteringham NR, Maggs JL, Pirmohamed M, and Williams DP (2005) The role of metabolic activation in drug-induced hepatotoxicity. Annu Rev Pharmacol Toxicol 45:177-202.
30. Pieper R, Gatlin CL, Makusky AJ, Russo PS, Schatz CR, Miller SS, Su Q, McGrath AM, Estock MA, Parmar PP, et al. (2003) The human serum proteome: display of nearly 3700 chromatographically separated protein spots on two-dimensional electrophoresis gels and identification of 325 distinct proteins. Proteomics 3:1345-1364.
31. Reilly TP, Bourdi M, Brady JN, Pise-Masison CA, Radonovich MF, George JW, and Pohl LR (2001) Expression profiling of acetaminophen liver toxicity in mice using microarray technology. Biochem Biophys Res Commun 282:321-328.
32. Rudolph KL, Trautwein C, Kubicka S, Rakemann T, Bahr MJ, Sedlaczek N, Schuppan D, and Manns MP (1999) Differential regulation of extracellular matrix synthesis during liver regeneration after partial hepatectomy in rats. Hepatology 30:1159-1166.
33. Ruepp SU, Tonge RP, Shaw J, Wallis N, and Pognan F (2002) Genomics and proteomics analysis of acetaminophen toxicity in mouse liver. Toxicol Sci 65:135-150.
34. Thome-Kromer B, Bonk I, Klatt M, Nebrich G, Taufmann M, Bryant S, Wacker U, and Kopke A (2003) Toward the identification of liver toxicity markers: a proteome study in human cell culture and rats. Proteomics 3:1835-1862.
35. Tolosano E and Altruda F (2002) Hemopexin: structure, function and regulation. DNA Cell Biol 21:297-306.
36. Tonge R, Shaw J, Middleton B, Rowlinson R, Rayner S, Young J, Pognan F, Hawkins E, Currie I, and Davison M (2001) Validation and development of fluorescence two-dimensional differential gel electrophoresis proteomics technology. Proteomics 1:377-396.
37. Trip JA, van Dam J, Eibergen R, and Que GS (1973) Investigations on correlations between serum enzymes and histological findings in liver disease. With special reference to transaminases and urocanase. Acta Med Scand 193:113-118.
38. Welch KD, Wen B, Goodlett DR, Yi EC, Lee H, Reilly TP, Nelson SD, and Pohl LR (2005) Proteomic identification of potential susceptibility factors in drug-induced liver disease. Chem Res Toxicol 18:924-933.
39. Yabe Y, Nishikawa M, Tamada A, Takakura Y, and Hashida M (1999) Targeted delivery and improved therapeutic potential of catalase by chemical modification: combination with superoxide dismutase derivatives. J Pharmacol Exp Ther 289:1176-1184.
40. Zieve L, Anderson WR, Dozeman R, Draves K, and Lyftogt C (1985) Acetaminophen liver injury: sequential changes in two biochemical indices of regeneration and their relationship to histologic alterations. J Lab Clin Med 105:619-624.